Atlas Trials

A Study to Evaluate Safety and Dosimetry of [18F]4-FDF, a New PET Imaging Agent for Inflammation

Clinical trial NCT07253753 · COMPLETED

Trial details

NCT number
NCT07253753
Sponsor
Yellowbird Diagnostics Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2026-04-08
Primary completion
2026-06-17
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.